# 2025年10月26日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 化学遗传学星形胶质细胞调控减少癫痫小鼠模型中的自发性海马放电和代谢物变化

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41137858](https://pubmed.ncbi.nlm.nih.gov/41137858)
**期刊：** Epilepsia
**PMID：** 41137858
**DOI：** 10.1111/epi.18684

### 第一部分 原文与翻译

**英文原标题：** Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse model.

**英文摘要原文：**
OBJECTIVES: Temporal lobe epilepsy (TLE) is characterized by recurrent, focal seizures, and up to one third of patients are not adequately treated by the current standard of care. This emphasizes the need for continued research into disease mechanisms and potential novel treatment strategies. In TLE, astrocytes transition to a reactive phenotype and we here investigate how modulation of their activity affects spontaneous seizures.

METHODS: We used Gq-coupled Designer Receptors Exclusively Activated by Designer Drugs (Gq-DREADD) to target reactive astrocytes in the intrahippocampal kainic acid (IHKA) mouse model for TLE. Through immunohistochemistry, we first verified the astrocyte-specific expression of Gq-DREADDs and we quantified astrocytic c-Fos expression upon Gq-DREADD activation. Spontaneous inhibitory post-synaptic currents (sIPSCs) were measured from dentate gyrus granule cells of live hippocampal slices before and after Gq-DREADD activation. Hippocampal field potentials were monitored in vivo to quantify seizure burden. Finally, metabolic profiling of the hippocampal tissue examined associated effects of Gq-DREADD activation in epileptic mice.

RESULTS: Gq-DREADD activation increased c-Fos expression in astrocytes but not in the neurons of the epileptic hippocampus and rapidly increased sIPSC in hippocampal slices from epileptic mice. We found a significant reduction in the number of spontaneous hippocampal paroxysmal discharges (HPDs) and overall seizure burden 1 day after Gq-DREADD modulation of reactive astrocytes. The metabolomics analysis at this time point showed 78 metabolites that were significantly altered in epileptic mice, 11 of which were also altered upon Gq-DREADD modulation of reactive astrocytes, belonging to several metabolic pathways that have been implicated in epilepsy.

SIGNIFICANCE: Our findings provide converging evidence for a modulatory role of reactive astrocytes in TLE. Gq-DREADD activation of hippocampal astrocytes suppressed HPDs and induced metabolic shifts, offering insight into astrocyte-driven mechanisms and potential therapeutic targets.

**中文摘要译文：**
目的：颞叶癫痫（TLE）以反复发作的局灶性癫痫为特征，高达三分之一的患者无法通过当前标准治疗得到充分治疗。这强调了继续研究疾病机制和潜在新型治疗策略的必要性。在TLE中，星形胶质细胞转变为反应性表型，我们在此研究调控其活性如何影响自发性癫痫发作。

方法：我们在海马内红藻氨酸（IHKA）小鼠TLE模型中，使用Gq偶联的设计受体仅由设计药物激活（Gq-DREADD）靶向反应性星形胶质细胞。通过免疫组织化学，我们首先验证了Gq-DREADDs的星形胶质细胞特异性表达，并量化了Gq-DREADD激活后星形胶质细胞c-Fos的表达。在Gq-DREADD激活前后，测量了活体海马切片齿状回颗粒细胞的自发性抑制性突触后电流（sIPSCs）。在体内监测海马场电位以量化癫痫负荷。最后，对海马组织进行代谢谱分析，检查Gq-DREADD激活在癫痫小鼠中的相关效应。

结果：Gq-DREADD激活增加了癫痫海马中星形胶质细胞而非神经元的c-Fos表达，并迅速增加了来自癫痫小鼠海马切片的sIPSC。我们发现，在反应性星形胶质细胞的Gq-DREADD调控后1天，自发性海马阵发性放电（HPDs）的数量和总体癫痫负荷显著减少。此时点的代谢组学分析显示，癫痫小鼠中有78种代谢物显著改变，其中11种在反应性星形胶质细胞的Gq-DREADD调控后也发生改变，这些代谢物属于多个与癫痫相关的代谢途径。

意义：我们的发现为反应性星形胶质细胞在TLE中的调控作用提供了汇聚证据。海马星形胶质细胞的Gq-DREADD激活抑制了HPDs并诱导了代谢转变，为星形胶质细胞驱动的机制和潜在治疗靶点提供了见解。

### 第二部分 AI 大师评价

本研究创新性地采用化学遗传学技术调控反应性星形胶质细胞，深入探索其在颞叶癫痫中的作用机制。通过Gq-DREADD特异性激活海马星形胶质细胞，研究不仅证实了其增强抑制性突触传递的能力，更重要的是发现了显著的抗癫痫效应——显著减少自发性海马阵发性放电和总体癫痫负荷。该研究的突出价值在于整合了电生理、代谢组学等多维度证据，揭示了星形胶质细胞调控对癫痫相关代谢途径的影响，为开发针对星形胶质细胞的新型抗癫痫治疗策略提供了重要理论基础。虽然研究局限于动物模型，但其发现的机制通路具有重要的转化医学潜力。

---

## 2. 单基因病因性失神发作癫痫的临床与遗传学特征全景分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41137852](https://pubmed.ncbi.nlm.nih.gov/41137852)
**期刊：** Epilepsia
**PMID：** 41137852
**DOI：** 10.1111/epi.18655

### 第一部分 原文与翻译

**英文原标题：** Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology.

**英文摘要原文：**
OBJECTIVE: To characterize the clinical, electroencephalographic, and genetic features of epilepsies featuring absence seizures within monogenic etiology, highlighting the diagnostic, treatment and prognostic implications.

METHODS: We conducted a retrospective, multicenter study including patients with monogenic epilepsies and electroencephalography (EEG)-documented absence seizures. We analyzed clinical data, electroclinical findings, neurodevelopmental outcomes, and treatment responses through standardized questionnaires and medical records. We classified genetic variants according to American College of Medical Genetics and Genomics (ACMG) guidelines and performed univariate and multivariate analyses to identify predictors of developmental outcomes.

RESULTS: We included 160 patients (111 female; median age at last follow-up: 13 years) with absence seizures and confirmed pathogenic or likely pathogenic monogenic variants. The most frequently implicated genes were SLC2A1, SLC6A1, SYNGAP1, CHD2, and SCN1A. Four genes-HESX1, NCKAP1, SON, STARD9-had not been previously associated with absence seizures. In 35% of patients, absence seizures were the only seizure type and in 67% were the initial manifestation. Atypical features included irregular EEG discharges (56%) eyelid myoclonia (42%), and automatisms (33%). Early-onset (before age 3) seizures occurred in 58% and was significantly associated with atypical features (p < .03). Using existing International League Against Epilepsy (ILAE) epilepsy syndrome classification, 60% of patients could not be classified. Developmental delay occurred in 54%, intellectual disability in 65%, and other neurodevelopmental comorbidities in 49%. Predictors of poor developmental outcomes included early developmental delay, drug-resistant epilepsy, and early absence onset. We found no difference in the prevalence of drug resistance across the various genetic etiologies. The most effective medications for absence seizures included valproate, ethosuximide, benzodiazepines, and lamotrigine. Disease-specific therapies (e.g., ketogenic diet in SLC2A1, stiripentol/fenfluramine in SCN1A) were effective in select cases.

SIGNIFICANCE: Absence seizures are a common manifestation of different monogenic epilepsies, often associated with early onset, atypical clinical and/or EEG features, developmental delay or drug resistance. Classification models should incorporate genetic data alongside electroclinical features, especially as next-generation sequencing is increasingly used.

**中文摘要译文：**
目的：描述单基因病因性失神发作癫痫的临床、脑电图和遗传学特征，重点阐明其诊断、治疗和预后意义。

方法：我们开展了一项回顾性、多中心研究，纳入单基因癫痫且经脑电图证实存在失神发作的患者。通过标准化问卷和医疗记录，我们分析了临床数据、电临床发现、神经发育结局和治疗反应。我们根据美国医学遗传学与基因组学学会指南对遗传变异进行分类，并进行了单变量和多变量分析以确定发育结局的预测因子。

结果：我们纳入了160名失神发作且确认携带致病性或可能致病性单基因变异的患者（111名女性；末次随访中位年龄：13岁）。最常涉及的基因是SLC2A1、SLC6A1、SYNGAP1、CHD2和SCN1A。四个基因——HESX1、NCKAP1、SON、STARD9——此前未发现与失神发作相关。在35%的患者中，失神发作是唯一的发作类型，在67%的患者中是首发表现。非典型特征包括不规则脑电图放电（56%）、眼睑肌阵挛（42%）和自动症（33%）。早发性（3岁前）发作发生在58%的患者中，且与非典型特征显著相关（p<.03）。使用现有的国际抗癫痫联盟癫痫综合征分类，60%的患者无法归类。发育迟缓发生在54%的患者中，智力障碍发生在65%的患者中，其他神经发育共病发生在49%的患者中。不良发育结局的预测因子包括早期发育迟缓、药物难治性癫痫和早发失神发作。我们发现不同遗传病因之间药物难治性的患病率没有差异。对失神发作最有效的药物包括丙戊酸、乙琥胺、苯二氮䓬类和拉莫三嗪。疾病特异性疗法（例如，SLC2A1中的生酮饮食，SCN1A中的司替戊醇/芬氟拉明）在特定病例中有效。

意义：失神发作是不同单基因癫痫的常见表现，通常与早发、非典型临床和/或脑电图特征、发育迟缓或药物难治性相关。分类模型应将遗传数据与电临床特征相结合，尤其是在下一代测序日益普及的情况下。

### 第二部分 AI 大师评价

本研究系统描绘了单基因病因性失神发作癫痫的临床与遗传学全景，填补了该领域的重要空白。通过160例患者的多中心回顾性分析，研究不仅确认了SLC2A1等已知基因的作用，还首次报道了HESX1等4个新基因与失神发作的关联，具有显著的创新性。研究揭示60%患者无法用现有ILAE分类系统归类，凸显了传统分类体系的局限性，为癫痫分类学革新提供了有力证据。临床价值在于明确了早发、非典型特征与不良预后的关联，并识别了有效的药物和疾病特异性疗法，对精准诊疗具有重要指导意义。研究局限性在于其回顾性设计，未来需要前瞻性研究进一步验证这些发现。

---

## 3. 毛果芸香碱诱导癫痫持续状态期间的呼吸功能障碍和致命性呼吸暂停

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41137579](https://pubmed.ncbi.nlm.nih.gov/41137579)
**期刊：** Epilepsia
**PMID：** 41137579
**DOI：** 10.1111/epi.18674

### 第一部分 原文与翻译

**英文原标题：** Respiratory dysfunction and fatal apnea during pilocarpine-induced status epilepticus.

**英文摘要原文：**
OBJECTIVE: Status epilepticus (SE) is second only to sudden unexpected death in epilepsy as a cause of seizure-related mortality. The progression of respiratory dysfunction during experimental SE remains poorly characterized. We investigated how pilocarpine-induced SE affects respiration in mice.

METHODS: We performed simultaneous plethysmographic, electroencephalographic, and electrocardiographic recordings in mice administered pilocarpine at 200, 240, or 280 mg/kg. We analyzed seizure progression, respiratory rate, ventilation, inspiratory/expiratory timing, and survival.

RESULTS: Higher pilocarpine doses resulted in shorter latency to SE and increased mortality. Across all doses, respiratory frequency and ventilation increased from baseline through early and established SE. There were respiratory abnormalities during SE, apneustic respiration, and pathological sigh, each associated with prolonged inspiration and expiration compared to eupneic respiration. Abnormal respiratory events occurred with similar frequency in both fatal and surviving animals. Death occurred during established SE. The sequence of events leading to death was a severe seizure, ending with tonic extension followed by terminal apnea. Seizure activity continued after apnea onset, followed by electrocerebral silence. Cardiac rhythm persisted beyond brain inactivity, gradually slowing to terminal arrest.

SIGNIFICANCE: Pilocarpine-induced SE leads to progressive, dose-dependent respiratory disturbances culminating in fatal apnea. These findings highlight the critical role of respiratory failure in SE-related death and underscore the need for real-time respiratory monitoring and early intervention during SE.

**中文摘要译文：**
目的：癫痫持续状态（SE）是仅次于癫痫猝死的癫痫相关死亡原因。实验性癫痫持续状态期间呼吸功能障碍的进展特征仍不清楚。我们研究了毛果芸香碱诱导的癫痫持续状态如何影响小鼠的呼吸。

方法：我们对给予200、240或280 mg/kg毛果芸香碱的小鼠同时进行体积描记、脑电图和心电图记录。我们分析了癫痫发作进展、呼吸频率、通气量、吸气/呼气时间以及存活情况。

结果：较高的毛果芸香碱剂量导致癫痫持续状态的潜伏期缩短和死亡率增加。在所有剂量下，从基线到早期和已建立的癫痫持续状态，呼吸频率和通气量均增加。在癫痫持续状态期间存在呼吸异常、长吸式呼吸和病理性叹息，每种异常与正常呼吸相比均与延长的吸气和呼气相关。异常呼吸事件在致命和存活动物中发生的频率相似。死亡发生在已建立的癫痫持续状态期间。导致死亡的事件序列是一次严重的癫痫发作，以强直性伸展结束，随后是终末性呼吸暂停。癫痫发作活动在呼吸暂停开始后持续，随后出现脑电静息。心脏节律在脑活动停止后持续存在，逐渐减慢至终末停搏。

意义：毛果芸香碱诱导的癫痫持续状态导致进行性、剂量依赖性的呼吸障碍，最终导致致命性呼吸暂停。这些发现突出了呼吸衰竭在癫痫持续状态相关死亡中的关键作用，并强调了在癫痫持续状态期间进行实时呼吸监测和早期干预的必要性。

### 第二部分 AI 大师评价

本研究通过多模态同步记录技术，系统揭示了毛果芸香碱诱导癫痫持续状态中呼吸功能障碍的进展机制。研究创新性地采用体积描记、脑电图和心电图同步监测，明确了癫痫持续状态导致进行性、剂量依赖性的呼吸异常，最终发展为致命性呼吸暂停的病理过程。该研究具有重要的临床价值，为理解癫痫相关死亡机制提供了新视角，强调了实时呼吸监测在癫痫持续状态管理中的必要性。然而，研究局限于动物模型，未来需要临床验证以指导人类癫痫持续状态的呼吸管理策略。

---

速递结束，祝您工作愉快！